Back

Categorization of patients with peripheral artery disease by charlson comorbidity index

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Risk of peripheral artery disease Peripheral Artery Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Max Maria Meertens

University Medical Centre of the Johannes Gutenberg University, Mainz (Germany)

6 More presentations in this session

Presentation thumbnail
Fine particulate matter exposure and the risk of peripheral revascularization: a post-hoc AIRCARD analysis
Doctor S. Mayntz (Odense, DK)
Abstract Slides Video
Presentation thumbnail
Impact of the below-knee lower extremity arterial calcification score on clinical outcomes in patients with intermittent claudication due to iliofemoral artery disease
Doctor K. Kawamura (Okayama, JP)
Abstract Slides Video
Presentation thumbnail
Longitudinal change in ankle-brachial index and incident cardiovascular disease and all-cause mortality
Doctor J. Song (Qingdao, CN)
Abstract Slides Video
Presentation thumbnail
Differences between female and male sarcopenic patients with peripheral artery disease
Doctor V. Schmitt (Mainz, DE)
Abstract Slides Video
Presentation thumbnail
Peripheral artery disease risk prediction in patients with severe aortic valve stenosis
Doctor M. Steinmetz (Bochum, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Risk of peripheral artery disease

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Comorbidity burden assessed by the charlson comorbidity index and its influence on prognosis of patients with pulmonary embolism
thumbnail
Congress Presentation
Developing a multi-center registry of peripheral artery disease using natural language processing: unlocking the power of the electronic health record
thumbnail
Congress Presentation
Differences between female and male sarcopenic patients with peripheral artery disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources